MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-MH-18-0008097
Euphoria Formulation Private Limited
Euphoria Formulation Private Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹10.2 Cr
▼ 20% YoY
Net profit · FY 2025
₹15.98 Lakh
Net margin 1.6%
EBITDA · FY 2025
₹38.95 Lakh
EBITDA margin 3.8%
Authorised capital
₹20 Lakh
Registered with MCA
Paid-up capital
₹5 Lakh
Issued & subscribed
Open charges
₹2.07 Cr
Satisfied ₹20 Lakh
Company age
21 yrs
Est. 2005
Directors on board
2
As per MCA filings
About Euphoria Formulation Private Limited
Data last updated:
Euphoria Formulation Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 16 June 2005 and has been in existence for over 21 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U51397MH2005PTC154012. Its GSTIN is 27AABCE5316M1ZJ (Maharashtra).
The company has an authorised share capital of ₹20 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors Nikhil Jain and Mishrimal Valchand Jain.
Its last annual general meeting (AGM) was held on 26 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 1/12 Varma Nagar Old Nagardas Road Andheri East, Mumbai, Maharashtra, India – 400069.
As per the financials filed for FY 2025, the company reported a revenue of ₹10.2 Cr, a decline of 20% compared to the previous year. For the same year it recorded a net profit of ₹15.98 Lakh (net margin 1.6%) and EBITDA of ₹38.95 Lakh (EBITDA margin 3.8%). Revenue has grown at a compounded annual rate (CAGR) of 6% over three years and 5% over five years.
As per MCA filings, the company has open charges of ₹2.07 Cr and satisfied charges of ₹20 Lakh on record. Court records list 1 case involving the company, including 1 filed against it; 1 case is pending.
Euphoria Formulation Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-18-0008097). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U51397MH2005PTC154012
Registration Number 154012
Incorporation Date 16 June 2005
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 26 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-MH-18-0008097
Recognitions & Rankings of Euphoria Formulation
Contact details
Euphoria Formulation Private Limited's registered office is in Mumbai, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address1/12 Varma Nagar Old Nagardas Road Andheri East, Mumbai, Maharashtra, India – 400069
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Euphoria Formulation Private Limited, buy the company report.
Comprehensive company report
Euphoria Formulation Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Euphoria Formulation is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 46 | Wholesale trade, except of motor vehicles and motorcycles |
To see the full business activity and turnover split of Euphoria Formulation Private Limited, buy the company report.
Financials of Euphoria Formulation Private Limited
FY 2025 filings availableEuphoria Formulation Private Limited reported revenue of ₹10.2 Cr (down 20% YoY) for FY 2025.
Revenue · FY 2025
₹10.2 Cr ▼ 20%
Net profit · FY 2025
₹15.98 Lakh margin 1.6%
EBITDA · FY 2025
₹38.95 Lakh margin 3.8%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 20%
3 years · compounded
▼ 6%
5 years · compounded
▲ 5%
EBITDA CAGR growth
1 year
▼ 5%
3 years · compounded
▲ 11%
5 years · compounded
▼ 2%
Revenue fell 20% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 5%. EBITDA fell 5% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹38.95 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹15.98 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.8% | ||||
| Net Profit Margin | 1.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Euphoria Formulation Private Limited, buy the company report.
Board of directors of Euphoria Formulation Private Limited
Euphoria Formulation has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Nikhil Jain Also directs: Nimiva Infra LLP | Director | 21 Jun 2011 | 15 Years 4 Months | Current |
| Mishrimal Valchand Jain | Director | 08 Sep 2009 | 17 Years 1 Months | Current |
Auditor
Euphoria Formulation Private Limited is audited by S G SALECHA & CO for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| S G SALECHA & CO | FY 2023 | 108986W |
Shareholding
The shareholding of Euphoria Formulation Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Euphoria Formulation Private Limited, buy the company report.
Charges & borrowings
Open charges
₹2.07 Cr
Satisfied charges
₹20 Lakh
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 09 Jun 2010 | 10230991 | Others | ₹2.07 Cr | Open | |
| 23 Feb 2006 | 90354693 | Vijaya Bank | ₹20 Lakh | Satisfied |
To see the full charge records of Euphoria Formulation Private Limited, buy the company report.
Total charge records: 2 View all charges
Legal cases
Euphoria Formulation Private Limited has 1 court case on record: 1 filed against it. All case is pending.
Total cases
1
Filed against the company
1
Pending
1
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 1 | 1 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Thane, Maharashtra | Court case (R.C.C.) | Filed against the company | Pending |
To see the full case history of Euphoria Formulation Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Euphoria Formulation Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Euphoria Formulation has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AABCE5316M1ZJ | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Euphoria Formulation Private Limited, buy the company report.
Recent activity
Euphoria Formulation Private Limited has 5 board changes on record since 2009: 2 appointments and 3 cessations. The latest: Nikhil Jain ceased to be Additional Director on 29 Sep 2016.
AGM
Euphoria Formulation Private Limited last Annual general meeting of members was held on 26 Sep 2025 as per latest MCA records.
Filing
Euphoria Formulation Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Charges
A charge with Others of Rs. 206.95 Lakh registered on 09 Jun 2010 with Charge ID 10230991 was modified on 16 Jun 2020.
Ceased
Nikhil Jain ceased to be Additional Director.
Charges
A charge registered on 23 Feb 2006 via Charge ID 90354693 with Vijaya Bank was fully satisfied on 01 Jul 2011.
Ceased
Chirag Jain ceased to be Director.
Appointed
Nikhil Jain was appointed as Director.
Charges
A charge with Others amounted to Rs. 206.95 Lakh with Charge ID 10230991 was registered on 09 Jun 2010.
Ceased
Bhavesh Jayantilal Shah ceased to be Director.
Appointed
Mishrimal Valchand Jain was appointed as Director.
Charges
A charge with Vijaya Bank of Rs. 20.00 Lakh registered on 23 Feb 2006 with Charge ID 90354693 was modified on 14 Mar 2008.
Charges
A charge with Vijaya Bank amounted to Rs. 20.00 Lakh with Charge ID 90354693 was registered on 23 Feb 2006.
1 earlier event is in the company report.
Frequently asked questions
Euphoria Formulation is an active private limited company based in Mumbai, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 16 June 2005 (21+ years old) and is registered under CIN U51397MH2005PTC154012.
Euphoria Formulation has 2 current directors:
- Nikhil Jain - Director
- Mishrimal Valchand Jain - Director
The latest financial statements of Euphoria Formulation on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 26 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Euphoria Formulation is 27AABCE5316M1ZJ, registered in Maharashtra.
The CIN (Corporate Identification Number) of Euphoria Formulation is U51397MH2005PTC154012. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Euphoria Formulation has 1 court case on record: 1 filed against it. 1 is pending.
Euphoria Formulation was incorporated on 16 June 2005, making it 21+ years old. It is registered with the Registrar of Companies, Mumbai.
Nikhil Jain ceased to be Additional Director on 29 Sep 2016. Chirag Jain ceased to be Director on 23 Jun 2011. Nikhil Jain was appointed as Director on 21 Jun 2011. Euphoria Formulation has 5 board changes on record in total.
Yes, Euphoria Formulation is registered as a small enterprise under Udyam registration (number: UDYAM-MH-18-0008097).
The registered office of Euphoria Formulation is at 112 Varma Nagar Old Nagardas Road Andheri East, Mumbai, Maharashtra, India – 400069.